" ( ) "

³ ( )

 (0)

 (0)

    
  1 / 1 |   | | | |  
 # 123428
Ѳ ˲ , Ӫ ˲, ʲ C CLDN6
      (uk)     (ru)     (en)      
( 20 .)
(11) 123428 (51) (2006)
C07K 16/28 (2006.01)
C12N 15/13 (2006.01)
A61K 39/395 (2006.01)
A61K 31/282 (2006.01)
A61K 31/337 (2006.01)
A61K 31/4745 (2006.01)
A61K 31/704 (2006.01)
A61K 31/7068 (2006.01)
A61K 47/68 (2017.01)
A61P 35/00
(24) 08.04.2021
(21) a201601865 (22) 30.07.2014
(31) PCT/EP2013/002272
(32) 31.07.2013
(33) EP
(41) 26.09.2016, . 18
(46) 07.04.2021, . 14
(56) WO 2011057788 A1, 19.05.2011
WO 2012003956 A1, 12.01.2012
Distinct expression pattern of claudin-6, a primitive phenotypic tight junction molecule, in germ cell tumours and visceral carcinomas / Tetsuo Ushiku, Aya Shinozaki-Ushiku, Daichi Maeda et al. // Histopathology. 2012. Vol. 61 (6). P. 1043-1056
Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cells / Uri Ben-David, Neta Nudel, Nissim Benvenisty // Nature Communications. 2013. Vol. 4. P. 1-8
Plasma Membrane Proteomics of Human Embryonic Stem Cells and Human Embryonal Carcinoma Cells / Wilma Dormeyer, Dennis van Hoof, Stefan R. Braam et al. // Journal of Proteome Research. 2008. Vol. 7. P. 29362951
Pamela A. Trail Antibody Drug Conjugates as Cancer Therapeutics / A. Pamela // Antibodies. 2013. Vol. 2 (1). P. 113-129
Kwon M. J. Emerging Roles of Claudins in Human Cancer / Mi Jeong Kwon // International Journal of Molecular Sciences. - 2013. - Vol. 14 (9). - P. 18148-18180
Turksen K. Claudins and Cancer Stem Cells / Kursad Turksen // Stem cell reviewz and reports. - 2011. - Vol. 7. - P. 797798
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer / Aleix Prat, Joel S. Parke, Olga Karginova et al. // Breast cancer research. - 2010. - Vol. 12 (5). - P. R68
Claudin 6: a novel surface marker for characterizing mouse pluripotent stem cells / Linlin Wang, Yan Xue, Yihang Shen et al. // Cell Research. - 2012. - Vol. 22 (6). - P. 1082-1085
(85) 26.02.2016
(86) PCT/EP2014/066330, 30.07.2014
(71) (DE ); Ͳ Ҳ (DE ); - ֲ Υ ͲDzIJֲ Х-ͲDz ֲ (DE )
...................................................................................................................................................................
(DE ); (DE ); - - (DE )
...................................................................................................................................................................
BIONTECH AG (DE ); GANYMED PHARMACEUTICALS GMBH (DE ); TRON - TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITATSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAT MAINZ GEMEINNUTZIGE GMBH (DE )
(72) Ӵ (FR ); (FR ); (DE ); (DE ); (DE ); (DE ); (DE )
...................................................................................................................................................................
(FR ); (FR ); (DE ); (DE ); (DE ); (DE ); (DE )
...................................................................................................................................................................
Sahin, Ugur (FR ); Tureci, Ozlem (FR ); Walter, Korden (DE ); Wagner, Meike (DE ); Kreuzberg, Maria (DE ); Hacker, Sabine (DE ); Jacobs, Stefan (DE )
(73) , An der Goldgrube 12, 55131 Mainz, Germany (DE ); Ͳ Ҳ , An der Goldgrube 12, 55131 Mainz, Germany (DE ); - ֲ Υ ͲDzIJֲ Х-ͲDz ֲ , Freiligrathstr. 12, 55131 Mainz, Germany (DE )
...................................................................................................................................................................
(DE ); (DE ); - - (DE )
...................................................................................................................................................................
BIONTECH AG (DE ); GANYMED PHARMACEUTICALS GMBH (DE ); TRON - TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITATSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAT MAINZ GEMEINNUTZIGE GMBH (DE )
(74)
(98)
/ 230, . , 01042
(UA)
(54) Ѳ ˲ , Ӫ ˲, ʲ C CLDN6
...................................................................................................................................................................
DIAGNOSIS AND THERAPY OF CANCER INVOLVING CANCER STEM CELLS
(57) [ ]
   
 
0.55587720871